Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated filings document operating results, material events and capital-structure activity for an aerospace components company listed on the New York Stock Exchange under TDG. Form 8-K reports include quarterly financial results, conference-call materials, acquisition-related events and exhibits furnished with company press releases.
The filing record also covers financing arrangements at subsidiary TransDigm Inc., including senior subordinated notes, term loans, indenture and guarantee disclosures. Governance filings report annual meeting voting outcomes, director elections, auditor ratification and advisory executive-compensation votes, alongside common-stock registration details and other material agreements.
TransDigm Group director W. Nicholas Howley, through the W. Nicholas Howley Family Trust, reported an option exercise and related share sales. The trust exercised stock options for 10,132 shares of TransDigm common stock at an exercise price of $50.9200 per share, converting them into 10,132 common shares.
The trust then sold 10,132 common shares in multiple open-market transactions on the same date at prices ranging from about $1,205.4151 to $1,231.3415 per share. Following these transactions, the trust continues to hold 21,547.513 TransDigm common shares indirectly attributed to Howley.
TransDigm Group’s Co‑Chief Operating Officer Joel Reiss exercised stock options and then sold shares in the open market. He exercised options for 3,900 shares of common stock at an exercise price of $284.97 per share and acquired the underlying shares.
On the same date, he sold 3,900 common shares in a series of transactions at prices around $1,222.87 to $1,250.65 per share, leaving him with 3,600 common shares held directly. Following the option exercise, he also continues to hold 27,500 stock options scheduled to expire on November 8, 2027. This filing reflects a routine exercise‑and‑sell transaction by a senior executive rather than a change in company operations.
TransDigm Group Incorporated reported the results of its 2026 Annual Meeting of Stockholders. Stockholders elected ten directors, including Jane M. Cronin, Michele L. Santana, and Robert J. Small, with each nominee receiving substantially more votes "for" than "withheld" and with broker non-votes recorded.
Stockholders also ratified Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026, with 51,593,887 votes for, 1,227,313 against and 12,544 abstentions. In an advisory vote, stockholders approved the compensation of the company’s named executive officers, with 48,583,255 votes for, 1,612,610 against, 20,962 abstentions and 2,616,917 broker non-votes. No other matters were submitted for a vote.
TransDigm Group Inc director Robert J. Small reported an indirect open‑market purchase by Stockbridge Fund, L.P. of 1 share of common stock at $1,285.00 per share on February 25, 2026. The filing notes this purchase was matchable under Section 16(b) with a prior sale of 1 share at $1,335.72 per share by an entity in which he has a pecuniary interest, and he paid the issuer the difference between the two prices. Following the transactions reported, indirect holdings include 366,142 shares held by Stockbridge Fund, L.P., 68,139 shares held by Stockbridge Partners LLC, and 60,246 shares held by certain family trusts, plus 5,625 shares held directly.
TransDigm Group’s Co-Chief Operating Officer Patrick Joseph Murphy exercised stock options and acquired common shares. On February 24, 2026, he exercised options for 1,160 shares and 300 shares of TransDigm common stock.
The 1,160 shares were acquired at $269.42 per share and the 300 shares at $347.17 per share through derivative exercises coded as “M.” Following these transactions, Murphy directly owned 2,515 shares of TransDigm common stock.
TransDigm Group Inc. reported insider activity involving a family trust associated with director W. Nicholas Howley. On February 18, 2026, the W. Nicholas Howley Family Trust u/a/d 4/23/99 sold 10,168 shares of TransDigm common stock in a series of open-market transactions. The weighted-average sale prices ranged from about $1,298.96 to $1,312.24 per share across the reported trades.
On the same date, the trust exercised stock options covering 10,168 shares of common stock at an exercise price of $50.92 per share, with the exercise price adjusted for dividends declared since August 1, 2022. After these transactions, the trust held 30,765.513 shares of common stock and 18,040 stock options indirectly.
TransDigm Group Co‑Chief Operating Officer Joel Reiss exercised stock options for 3,900 shares of common stock at an exercise price of $284.97 per share and received the underlying shares on February 17, 2026.
On the same day, he sold 3,900 TransDigm common shares in multiple open‑market transactions at prices generally between about $1,279 and $1,305 per share. After these trades, Reiss directly holds 3,600 shares of common stock and 31,400 stock options.
TransDigm Group insider plans a Rule 144 share sale. A person identified as JOEL B REISS filed to sell 15,600 shares of TransDigm common stock through Morgan Stanley Smith Barney, with an aggregate market value of 20,072,052.00, on or about 02/17/2026 on the NYSE.
The shares were acquired the same day via an exercise of stock options for cash. The notice states there were 56,473,563 common shares outstanding. Over the prior three months, the filer’s 10b5-1 sales included 3,900 shares on 01/15/2026 for gross proceeds of 5,576,694.63 and 3,900 shares on 12/15/2025 for 5,033,033.46.
TransDigm Group Incorporated reported that its subsidiary TransDigm Inc. has completed $2,000 million of new debt financing to support previously announced acquisitions. The financing includes $1,200 million of 6.125% senior subordinated notes due July 31, 2034 and $800 million of new tranche N term loans maturing February 13, 2033. The notes were issued at 100% of principal, pay 6.125% interest semi-annually starting July 31, 2026, and are guaranteed on a senior subordinated basis by TD Group and certain restricted subsidiaries. The term loans bear interest at Term SOFR plus a 2.50% margin and were fully drawn on February 13, 2026. TransDigm intends to use the net proceeds, along with cash on hand, to fund the aggregate purchase price of Stellant Systems, Inc., Jet Parts Engineering, Victor Sierra Aviation Holdings and related transaction fees and expenses.